Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Cash & Equivalents: 2020-2022

Historic Cash & Equivalents for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $143.2 million.

  • Terns Pharmaceuticals' Cash & Equivalents fell 39.83% to $37.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $37.9 million, marking a year-over-year decrease of 39.83%. This contributed to the annual value of $143.2 million for FY2022, which is 200.29% up from last year.
  • As of FY2022, Terns Pharmaceuticals' Cash & Equivalents stood at $143.2 million, which was up 200.29% from $47.7 million recorded in FY2021.
  • Terns Pharmaceuticals' Cash & Equivalents' 5-year high stood at $143.2 million during FY2022, with a 5-year trough of $47.7 million in FY2021.
  • For the 3-year period, Terns Pharmaceuticals' Cash & Equivalents averaged around $88.6 million, with its median value being $74.9 million (2020).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first slumped by 36.28% in 2021, then soared by 200.29% in 2022.
  • Over the past 3 years, Terns Pharmaceuticals' Cash & Equivalents (Yearly) stood at $74.9 million in 2020, then tumbled by 36.28% to $47.7 million in 2021, then surged by 200.29% to $143.2 million in 2022.